SCHEMBL352098

SCHEMBL352098

CNC(=O)c1csc(-c2cccs2)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.68
HPGD P15428 2/20 0.64
ALDH1A1 P00352 2/20 0.59
RAB9A P51151 7/20 0.58
NPC1 O15118 4/20 0.58
POLB P06746 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
GAA P10253 2/20 0.57
HDAC3 O15379 1/20 0.57
HDAC1 Q13547 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
LMNA P02545 1/20 0.52
CHEK1 O14757 1/20 0.52
MEN1 O00255 1/20 0.50
MAPT P10636 1/20 0.50
CASP3 P42574 1/20 0.50
KMT2A Q03164 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12224721 0.85 KDM4E (0.68) KDM4EHPGDALDH1A1RAB9ANPC1
SCHEMBL23792544 0.83 KDM4E (0.73) KDM4EHPGDALDH1A1RAB9ANPC1
SCHEMBL27906338 0.82 KDM4E (0.78) KDM4EHPGDALDH1A1RAB9ANPC1
SCHEMBL656958 0.81 KDM4E (1.00) KDM4EHPGDALDH1A1RAB9ANPC1
SCHEMBL13638811 0.80 RAB9A (0.63) KDM4EHPGDALDH1A1RAB9ANPC1
SCHEMBL3065986 0.80 KDM4E (0.73) KDM4EHPGDRAB9ANPC1POLB
SCHEMBL2691717 0.80 KDM4E (0.73) KDM4EHPGDALDH1A1RAB9ANPC1
Hydrochloric Acid SCHEMBL6822052 0.80 KDM4E (0.97) KDM4EHPGDALDH1A1RAB9ANPC1
SCHEMBL25474267 0.79 KDM4E (0.68) KDM4EHPGDALDH1A1RAB9ANPC1
SCHEMBL10851498 0.78 HPGD (1.00) HPGDRAB9ANPC1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365927-A1 COMPOSITION AND METHOD FOR TRANSDIFFERENTIATING NON-NEURONAL CELLS INTO NEURONS INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES (CN) 2023-11-16 US claimed
EP-4230731-A1 COMPOSITION AND METHOD FOR TRANSDIFFERENTIATING NON-NEURONAL CELLS INTO NEURONS Institute Of Zoology, Chinese Academy Of Sciences (CN) 2023-08-23 EP claimed
CN-114369572-A Composition and method for transdifferentiating non-neuronal cells into neurons 中国科学院动物研究所 2022-04-19 CN claimed
US-20230365927-A1 COMPOSITION AND METHOD FOR TRANSDIFFERENTIATING NON-NEURONAL CELLS INTO NEURONS INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES (CN) 2023-11-16 US disclosed
EP-4230731-A1 COMPOSITION AND METHOD FOR TRANSDIFFERENTIATING NON-NEURONAL CELLS INTO NEURONS Institute Of Zoology, Chinese Academy Of Sciences (CN) 2023-08-23 EP disclosed
WO-2022077549-A1 COMPOSITION AND METHOD FOR TRANSDIFFERENTIATING NON-NEURONAL CELLS INTO NEURONS 中国科学院动物研究所 2022-04-21 WO disclosed
CN-114369572-A Composition and method for transdifferentiating non-neuronal cells into neurons 中国科学院动物研究所 2022-04-19 CN disclosed
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US disclosed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds NAAA, AADAC, RPSA KDM4E 1862/4885HPGD 1814/4885ALDH1A1 2806/4885
US-20230365927-A1 COMPOSITION AND METHOD FOR TRANSDIFFERENTIATING NON-NEURONAL CELLS INTO NEURONS MYO1B, MYH14, MYO3A KDM4E 1467/4885HPGD 1854/4885ALDH1A1 1553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.